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Abstract
The wide use of microbicide is mainly depends on its effectiveness, less frequent application, 
ready availability and most importantly cost. The aim of this work was to develop affordable microbicide 
mucoadhesive gel formulation of synthetic anti HIV drug, stavudine and to characterise it in terms 
of its physical properties, mucoadhesiveness and spreadability. The purpose of the present study 
was also to compare different dissolution media used for in vitro release of vaginal dosage form. The 
gels were tested for antimicrobial, spermicidal and anti-HIV activity. Gels prepared using Carbopols 
and Polycarbophil were transparent and homogenous and had excellent mucoadhesion index - and 
showed fast drug release profile. Gels showed very good antimicrobial action against pathological 
microorganism. 
to combat costs, side effects, and local tissue drug distribution 
limitations. In this research, an attempt was made to formulate 
stavudine, a synthetic thymidine nucleoside analogue mucoadhesive 
microbicide gel. Three polymers were used at three different 
concentrations to produce gels. Prepared gels were evaluated mainly 
for their mucoadhesiveness, drug release profile and antimicrobial 
action.
Materials and Method 
Stavudine was obtained as gift sample from Alkem Laboratories, 
Mumbai, India. Gelling agents such as Carbopol 934P (C934P), 
Carbopol 974P (C974P), Hydroxy propyl methylcellulose (HPMC), 
methylcellulose (MC) and carboxy methyl cellulose (CMC) were 
obtained as generous gift sample from Signet Chemicals, Mumbai, 
India. Polycarbophil (PCL) was provided by Noveon, Mumbai, India. 
Experimental
Formulation of microbicide gel
Microbicide gels were prepared using various percentages (1 
to 3%) of two Carbopol grades 934P and 974P and Polycarbophil. 
Varying percentages from 1-5% of gelling agent were tried to produce 
smooth gel of HPMC, MC and CMC. Weighed quantity of gelling 
agent was soaked overnight in measured quantity of water. Next day 
the polymer was mixed with drug solution and humectant (glycerin 
5%) under slow stirring to get a uniform mix. Gels prepared with both 
the Carbopol type were neutralized using 10% NaOH solution and 
pH was maintained between 4 and 5 (Table 1).
Evaluation of microbicide gels 
Gels were evaluated for various physiochemical parameters such 
as appearance, pH, drug assay, spreadability, mucoadhesiveness, in 
vitro drug release and in vitro penetration through sheep vaginal 
mucosa. In addition, antimicrobial, anti-spermicidal and anti-HIV 
activity was carried out for developed microbicide gel.
Introduction
Lots of efforts are being done in the field of new products and 
combination product for antiretroviral therapy based on novel 
as well as conventional drug delivery technology. Researchers are 
trying to combine substances with different mechanism of action to 
synergies the effectiveness [1-3]. The most effective routes of HIV 
transmission are sexual transmission from infected individuals. The 
exact mechanism of such transmission remains unclear. Currently 
an estimated 47-53 million women worldwide are living with HIV/ 
AIDS [4]. Women’s are 4-16 times more likely to contract HIV 
from infected males than vice versa and young women are especially 
vulnerable.
The cervix is the main port of entry for HIV in women, blocking 
the cervix may have a big impact on HIV transmission. The genital 
viral load might serve as a better estimate for the transmission, 
being the distinct microenvironment that permits viral replication 
independent from the systemic circulation. Microbicide would 
provide protection by directly inactivating HIV or preventing HIV 
from attaching, entering or replicating in susceptible target cells as 
well as dissemination from target cells percent in semen or the host 
cells that line the vaginal or rectal wall [5]. 
Microbicides are products for vaginal administration that can be 
used to prevent HIV infection and other sexually transmitted diseases 
(STDs), it may be gel or cream or other form that could be applied to 
genital mucosae to prevent or significantly reduce the transmission 
of HIV and other disease causing organisms [6,7]. Most microbicides 
under development acts by either killing or inactivating pathogens, 
by breaking down the surface or envelop of the virus or pathogens, 
by creating physical barriers, by strengthening the body’s normal 
defenses such as vaginosis natural acidity, by inhibiting viral entry 
by blocking site or preventing HIV attachment and inhibiting viral 
replication.
There is urgent need to develop a suitable drug delivery system 
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Percent drug content 
Percent drug content of stavudine gels was determined 
partitioning drug into aqueous phase. Accurately weighed 100 mg 
gels were taken in a separating flask containing 100 ml of water or 
pH 7.2 buffer flask was shaken vigorously for 10 min., followed by 
filtration (0.45 µm). The percent drug extracted in aqueous phase 
was determined by UV spectrophotometry (Jasco Instrument) at 
wavelength of 265 nm. 
Spreadability index
The in vitro spreadability check was performed on drug containing 
gels which can act as an indicator how is the spread on the skin or 
mucosa surface when applied. The spreadability apparatus equipped 
with a pan, rectangular glass side and a wooden block was used for 
this study. The gel was placed in the middle of wooden block and glass 
slide was placed on it and allowed to stand for 5 min under weight 
of 300g to allow uniform gel film formation and to expel entrapped 
air. Later, the time was noted to move glass slide from the wooden 
box by adding weight of 100 g in pan till it completely separates from 
box surface. The spreadability index was calculated by time required 
in seconds for the plate to detach divided by total weight of the gel 
placed on the wooden surface in grams.
Mucoadhesiveness
Fresh sheep vaginal mucosa was obtained from a local 
slaughterhouse. The underlying fat and loose tissues very removed to 
obtain uniform mucosal lining. The mucosal membrane was washed 
with distilled water twice followed by saline solution. The bioadhesive 
strength of the gel was determined in triplicate. The mucosa was 
cut and tied to the Teflon cylinder and placed in 50 ml beaker filled 
with simulated vaginal fluid. A gel was applied on the surface of 
mucosa. Another hanging Teflon cylinder from balance was placed 
on mucosal surface containing gel and allowed in contact for 30 sec. 
The weights were added in another pan of balance slowly. The mass, 
in grams, required to detach the Teflon cylinder from the mucosal 
surface was noted. The mucoadhesion index was calculated using 
following equation. 
( ) bioadhesive strengthForce of adhesion N     9.81
1000
= ×
In vitro drug release 
Literature reports use of various media for dissolution of vaginal 
dosage form. We studied the effect of dissolution media on in vitro 
drug release from mucoadhesive vaginal gel of an anti HIV drug. 
Simple USP paddle apparatus was used for carrying out dissolution 
studies in 200ml of dissolution media at 37 ± 0.5°C and at 50 rpm. 
Total nine different media were investigated reported in literature e.g. 
distilled water pH7 (DW), citrate buffer B.P pH4.8 (CBBP),  normal 
saline pH4.8 (SLN), citrate buffer pH 4.8 (CB) [8], acetate buffer pH6 
(AB), acetate buffer with dioxane pH4.8 (ABWD) [9], phosphate 
citrate buffer pH4.8 (PCB)[10], modified citrate buffer pH5.5(MCB) 
[11] and simulated vaginal fluid pH4.2 (SVF) [12]. 
About 100 mg of gels was placed on glass slide and inserted 
in medium. Five milliliter of aliquot was withdrawn at each time 
intervals 30 min, 1-8 and 24 h from each dissolution vessel and filtered 
through 0.45µm membrane. The dissolution for respective blank gel 
was also performed. The drug content in aliquots was analyzed using 
spectrophotometer at wavelength of 265 nm.
In vitro drug penetration studies
In vitro drug penetration studies on selected batches were carried 
out using Franz diffusion cell at 50 rpm. The best medium selected 
from release study i.e. a simulated vaginal fluid (pH 4.8) was used 
as dissolution media (20 ml) maintained at 37 ± 0.2ºC. The weighed 
quantity gels (containing 100 mg drug) were placed on sheep vaginal 
mucosa as barrier.  One milliliter of aliquots were withdrawn at time 
intervals 30 min, 1-8 and 24 h and filtered through 0.45µm. The drug 
content of samples was determined spectrophotometrically at 265 nm 
against blank gels. 
Spermicidal activity
Spermicidal activity was determined on freshly obtained 
semen samples using modified Sander Cramer technique [13]. The 
spermicidal activity on pure drug at concentrations ranging from 
0.25% to 10% and formulated gel was performed. This test indicates 
the minimum concentration of spermicidal agent required to kill 
100% of the sperms within 20 secs. The various test concentrations 
were mixed with 20 µL sperm suspension and observed under 
microscope at 400x magnification, the time was recorded at which 
the sperm loses its motility. 
Anti-microbial activity
Developed gel formulations were checked against various gram 
+ve (e.g. Staphylococcus aureus (ATCC 25923), Bacillus subtilis 
(ATCC 6633), Streptococcus faecalis (ATCC 29212)) and gram –
ve microorganisms (e.g. Pseudomonas aeruginosa (ATCC 27853), 
Klebsiella pneumoniae (ATCC 13883), Escherichia coli (ATCC 
25922), Salmonella typhi (ATCC 6539)), Antifungal activity was 
checked against Candida albicans (ATCC 10231).  The antimicrobial 
activity was tested by using agar diffusion method under aseptic 
conditions. Primarily inhibitory concentrations were determined 
using ditch plate method. A solution of stavudine in phosphate 
buffer saline and cloramphenicol (100µg) and clotrimazole (25µg) in 
DMSO was used in this study. Antimicrobial assay was performed 
using a nutrient agar and Sabourad dextrose agar as dehydrated 
media by applying cup plate technique. Initially, culture solution was 
prepared to get concentration of 1x106 microorganisms/ml which 
Independent variables
Levels
C-934 C-974 PCL
A) Conc. of  gelling agent (%w/w) 1 2 3
B) Stirring speed 100 200 300
C)  % Drug 1 1 1
Table 1: Formulation optimization of stavudine microbicide gel.
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was matched with McFarlands Standard No. 1 (0.1ml of 1% aqueous 
barium chloride solution added to 9.9ml of 1% H2SO4). On the other 
hand, 30ml of sterile agar bed containing one milliliter of culture 
suspension (1x106 microorganisms/ml) was prepared under sterile 
conditions. In the solidified agar, cups of 13 mm diameter were bored 
using sterile cork borers. A test and standard solutions were added to 
the cups on the agar plates aseptically and incubated at 37 ± 2ºC for 
24 hours. The plates culturing Candida albicans were incubated at 
lower temperature of 25 ± 2ºC. After 24h, the zones of inhibition were 
measured in millimeter.
Anti-HIV activity
The p24 antigen assay detects the soluble viral p24 protein content 
and is more sensitive than the reverse transcriptase assay. A H9-based 
in vitro method has been developed for the evaluation of anti-HIV 
activity of developed gel. The H9 cells were procured from National 
Centre for Cell Sciences, Pune, India. The virus was allowed to adsorb 
onto the cells followed by centrifugation and resuspension into fresh 
growth medium ensuring complete removal of soluble virus non-
associated p24 antigen. These infected H9 cells were incubated in 
presence of test sample. The cell free supernatant was collected by 
centrifugation, and analyzed for p24 antigen. This detection was 
performed using a commercially available ELISA kit (Zeptometrix, 
California, USA) and percent cell inhibition was calculated. 
Results and Discussion
Formulation of microbicide gel
The transparent gels of Carbopol 934, 974 and Polycarbophil, 
blank and stavudine loaded can be prepared easily and has pH in range 
of 4.6 - 4.8 without any sign of precipitation. All gels showed very high 
mucoadhesive strength when tested on vaginal mucosa, increase in 
polymer percentage showed increased degree of mucoadhesiveness. 
The viscosity of prepared gels was in between 1.5 to 2.5 cps depending 
upon the polymer concentration. This mucoadhesive property can 
serve as an important parameter in sustaining drug delivery, and 
simultaneously providing a good physical barrier for HIV migration 
from semen to vaginal tissue until reasonable residence time. All 
three gels were homogeneous, odorless and readily water washable. 
As stavudine is freely water soluble, it was easier to prepare varied 
concentrations of drug in gel (Table 2). The percent drug content was 
found to be 97-98%, suggested that drug was distributed evenly at 
all speed of stirring. The low and moderate stirring speed resulted 
in formation of homogeneous gels with minimum air entrapment, 
whereas high speed of 500 rpm showed significant degree of air 
entrapment. Gels prepared with HPMC, MC and CMC even at 5% 
concentration were less mucoadhesive and showed poor spreadability. 
Literature reports incorporation of synthetic antiretroviral drug like 
saquinavir [14], theaflavin [15] tenofovir [16,17] and dapivirine [18-
20], IQP-0528, a pyrimidinedione analog [21], retrocyclin 1 analog 
RC-101 [22], octylglycerol [23] and for HI-443 (N’-[2-(2-thiophene)
ethyl]-N’-[2-(5-bromopyridyl)] thiourea] [24] as microbicide 
candidate. The spreadability of the gels was found to be in the range 
of 5-26 seconds. 
In vitro drug release 
The objective was to evaluate the effect of type of media and 
its composition on drug release. Many reports are published using 
single media for release depending on type of vaginal dosage forms, 
but none of the report compares different media for one formulation 
containing single drug. In this study, the type of dissolution media 
showed a marked effect on release of stavudine all gel formulations. 
In the citrate buffer and simulated vaginal fluid comparative faster 
drug release to other media with t50% of 9.25 min and 90% of 30 min 
in case of simulated vaginal fluid and 1h in case of citrate buffer B.P. 
The initial drug release was slow in acetate buffer containing dioxane 
(t50% = 12.78 min) with comparable t90% (29.75 min) (Figure 1). 
When dioxane was not added to the acetate buffer slow stavudine 
release was obtained (t50% of 23.44 min.), although within one hour 
90% of drug was released. The release of stavudine was very slow in 
modified citrate buffer with t50% of 43.32 min and t90% of the 2.94h 
(Table 3). In distilled water as dissolution media, the drug release 
was found to be the slowest (t50% of >1h, t90% > 3h). The order of 
release of drug in dissolution media was arranged from fastest to 
slowest in following sequence SVF > CBBP > AB > CB= PCB=SL> 
ABWD > MCB> DW. The type of dissolution media, pH of media 
and composition played critical role in determining drug release from 
gels. Simulated vaginal fluid showed fastest drug release had an acidic 
pH of 4.2 while the water which showed slowest drug release had pH 
7. The other media had pH of 4.8. The presence of dioxane in acetate 
buffer resulted in faster drug release as compared to ABWD which 
did not have dioxane. Similarly with increasing quantities of sodium 
citrate in modified citrate buffer, citrate buffer and citrate buffer B.P., 
respectively the drug release was found to increase. Thus, selection of 
dissolution media is an important consideration for carrying out in 
vitro drug release studies from vaginal formulation. 
In vitro drug penetration studies
Permeation studies through vaginal sheep mucosa showed all 
most similar release behavior from all gel formulations. About 28% 
Batch Appearance pH Mucoadhesive index Spreadability
C934P-1 [0.75%] Transparent 4.2 1.30 6.26
C934P-1 [1%] Transparent 4.7 9.67 21.48
C934P-1 [1.5 %] Transparent 4.3 12.33 28.81
C974P-1 [0.75%] Transparent 4.6 5.21 5.34
C974P-1 [1%] Transparent 4.3 10.65 24.01
C974P-1 [1.5 %] Transparent 4.5 13.15 26.42
PCL-1 [0.75%] Transparent 4.8 9.63 6.91
PCL-1 [1%] Transparent 4.6 12.89 24.56
PCL-1 [1.5 %] Transparent 4.6 15.01 25.78
MBHPMC Transparent 4.3 3.15 6.12
MBMC Transparent 4.3 1.87 3.83
MBCMC Transparent 4.4 2.32 5.11
Table 2: Evaluation parameters of gels prepared with Carbopol 934P (C934P), 
Carbopol 974P (C974P) and Polycarbophil (PCL). Batch C934P-1% showed 
ideal characteristic for use as microbicide gel.
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Figure 1: In vitro release profile of stavudine at various time points from microbicide gel  prepared using Carbopol 934P, Carbopol 974P and Polycarbophil (1%) 
in acetate buffer without dioxane (ABWD), Citrate buffer/ British pharmacopoeia (CBBP), phosphate citrate buffer (PCB), acetate buffer (AB), distilled water (DW), 
modified citrate buffer (MCB), saline (SLN), citrate buffer (CB) and simulated vaginal fluid (SVF).
Batch % Assay
In vitro drug release [%] In vitro penetration [%]
t50% t90% 12 h 24 h
C934P-1 [0.75%] 99.37 7.50 24.26 - -
C934P-2 [1%] 98.43 9.24 29.96 28.12 60.01
C934P-3 [1.5 %] 97.20 12.22 35.86 - -
C974P-1 [0.75%] 98.45 8.34 28.56 - -
C974P-1 [1%] 97.87 10.07 32.15 30.88 65.03
C974P-1 [1.5 %] 99.01 17.45 41.04 - -
PCL-1 [0.75%] 98.34 7.56 27.89 - -
PCL-1 [1%] 97.99 13.98 36.25 35.71 73.45
PCL-1 [1.5 %] 99.45 16.77 45.23 - -
MBHP 96.68 11.52 56.12 42.37 80.12
MBMC 98.32 11.51 54.42 69.12 70.11
MBNAC 101.01 21.39 57.05 46.87 74.12
Table 3: Drug content, release pattern in terms of t50% and t90% when performed in simulated vaginal fluid as dissolution medium and in vitro penetration of selected 
stavudine gel batches from sheep vaginal mucosa.
drug was release at end of 12 hours from C934P and C974P while 
it took 2 more hours for Polycarbophil gel to reach that level. At 
24th, almost 60-65% drug was penetrated from both Carbopol gels 
and 73% for Polycarbophil gel (Table 3). This penetrated drug 
concentration can kill virus which escaped by physical barrier formed 
by gelling polymer. It is a sufficient concentration to kill mucosal viral 
reservoirs.
Spermicidal activity
Sander Cramer test indicated spermicidal activity within one 
minute. All the gels were compared with the control (0.9% saline). 
The sperms when mixed with the control maintained its motility for 
more than 4h. A drug dose dependant decrease in the immobilization 
of sperm was observed. The respective blank (placebo) gels did not 
show any effect on the sperm motility till 60 min. The drug solution 
and gels formulated with Carbopol 934, 980 and Polycarbophil 
containing 1% drug were also evaluated for their in vitro spermicidal 
activity. At the concentration of 6%, almost 100% of the sperms were 
immobilized within 20 seconds (Table 4). 
Anti-microbial activity
The stavudine drug solution showed a good antibacterial activity 
on cup plate method, a concentration dependent increase was found 
in the zone of inhibition, with 50 mg/ml having the maximum 
inhibition. The results are depicted in Table 5 and Figure 2. The gels 
at 1% drug concentration showed good activity against the gram-
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Time [min] / % drug sol
0 1 2 3 4 5 6 7 8 9 10
% spermicidal activity 20 µl : 20 µl
0.25 20 15 10 10 10 5 5 3 3 3 3
0.5 2 1 1 1 1 1 1 1 1 - -
1 1 1 1 1 1 1 1 1 1 - -
2 1 1 1 1 1 1 Nil - - - -
4 1 1 1 Nil - - - - - - -
6 1 1 Nil - - - - - - - -
8 1 1 Nil - - - - - - - -
10 1 1 Nil - - - - - - - -
50µl  :   20µl
4% 0.5 Nil - - - - - - - - -
6% Nil Nil - - - - - - - - -
8% Nil Nil - - - - - - - - -
C934P-1% gel 0.5 Nil - - - - - - - - -
Table 4: In vitro spermicidal activity of stavudine solution and microbicide gel when mixed with semen sample at ratio of 20 µl: 20 µl and 50 µl: 20 µl at different time 
points.
Sr. No
Microorganisms
Zone of inhibition [mm] [50 mg/ml]
Standard  (100 µg/cup) Chloramphenicol
1 2 Avg
Gram + Ve
1. Staphylococcus aureus [ATCC 25923] 19.80 21.12 20.46 20.12
2. Bacillus subtilis[ATCC 6633] 16.38 17.98 17.18 18.73
3.
Streptococcus faecalis
[ATCC 29212] 20.12 20.98 20.55 21.71
Gram -Ve
4. Escherichia coli[ATCC 25922] 19.78 21.32 20.55 20.30
5. Klebsiella pneumonia[ATCC 13883] 16.10 16.80 16.45 19.50
6 Pseudomonas aeruginosa [ATCC 27853] 18.60 19.36 18.98 20.20
7
Salmonella typhii
[ATCC 25923] 17.30 18.05 17.67 19.20
Fungi
8 Candida albicans[ATCC 6539] 18.30 19.01 18.65 22.00
Table 5: Antimicrobial activity of stavudine microbicide gel in various gram positive, gram negative organism and fungi compared to standard cloramphenicol when 
tested by cup plate method.
negative organisms, Escherichia coli and Pseudomonas aeruginosa 
and slightly less activity against Klebsiella pneumonia and Salmonella 
typhi with the zones of inhibition of 20.55, 18.98, 16.45 and 17.67 mm, 
respectively. These gels also showed moderate activity with the zones 
of inhibition of 17.18 and 20.55mm against gram positive organisms 
Bacillus subtilis and Streptocococcus faecalis at 175mg. The zones of 
inhibition of gel (18.65 mm) were comparable to clotrimazol (22.00 
mm) when tested against fungi Candida albicans.
Anti-HIV activity
The Carbopol934P gel (batch C934P-1%) showed promising anti-
HIV activity when tested by p24 antigen method. About 80 to 90% 
anti-HIV activity was observed for gels containing 1% drug. The MTT 
assay showed more than 85% of cell viability. An increase in drug 
Citation: Shegokar R, Singh KK (2015) Development of Mucoadhesive Gel Microbicide to Target Mucosal HIV Reservoirs. J HIV Clin Scientific Res 2(1): 
001-007.
Shegokar and Singh  (2015) 
006
Zone of inhibition for Candida albicans and E coli
Zone of inhibition for Klebsiella pneumonia, Salmonella typhii and P. aeruginosa
Zone of inhibition for Staphylococcus a, Bacillus subtilis and streptococci faecalis
Figure 2: Photomicrographs agar plates showing the zone of inhibition of stavudine microbicide gel against various microorganims and fungi.
concentration showed further increase in activity. The placebo gel 
also showed anti-HIV activity to lesser extent (10-15%).
Conclusion
Antiretroviral drug Tenofovir as gel microbicide significantly 
inhibited HIV transmission in clinical trial. This study indicates 
that a synthetic drug “stavudine” which is easily available and 
affordable can be considered as suitable candidate for development 
of microbicide formulation. The multifunctional mucoadhesive gels 
have a very good antimicrobial, anti HIV and spermicidal activity and 
can be easily prepared using three different polymers. The developed 
gels needs to be tested in vivo in suitable animal model to confirm the 
results obtained in vitro. 
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